SUD Residential denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for sud residential are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies Residential SUD Treatment as Duplicate Therapy

A duplicate-therapy denial for residential substance use disorder (SUD) treatment usually means BCBS has a concurrent claim on file — or a recent claim — for another level of care or service that it considers to be providing the same function. Common triggers include: an overlapping intensive outpatient (IOP) or partial hospitalization program (PHP) claim; a billing overlap between the residential facility and an individual outpatient provider; or a prior residential admission within the same treatment episode that BCBS treats as a continuation rather than a new level-of-care need.

This denial type is frequently erroneous and is strongly appealable. Residential treatment and outpatient levels of care serve different clinical functions and are not interchangeable under the ASAM Criteria, which is the standard level-of-care framework for SUD treatment.

## Your Federal Appeal Rights

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), BCBS cannot apply more restrictive coverage rules to SUD treatment than it applies to analogous medical or surgical benefits. A duplicate-therapy denial applied to residential SUD but not to comparable medical admissions may constitute a parity violation. ACA §2719 external review rights apply to non-grandfathered plans; the external review window is approximately four months from the denial. ERISA §503 full-and-fair review applies to employer-sponsored plans. Request the specific clinical criteria used for the denial in writing.

## How to Appeal

Step 1 — Clarify the overlap: Contact BCBS claims to identify exactly which claim or authorization they consider duplicative. Get the claim number and the basis for the determination in writing.

Step 2 — Document clinical differentiation: Your appeal must establish that the residential level of care was clinically distinct from and not duplicative of any other concurrent service. The treating clinician's documentation of the patient's clinical needs at the time of admission is central to this argument.

## Documentation to Gather

• ASAM Criteria assessment performed at residential admission, showing the clinical dimensions that supported the residential level-of-care placement
• Admission notes documenting clinical severity, safety considerations, and why a lower level of care was insufficient at that time
• Any discharge or transition records from prior level of care showing the clinical trajectory that led to residential placement
• A letter from the treating clinician explaining why residential treatment was clinically distinct from the service BCBS identified as duplicative
• BCBS's written statement of the specific basis for the duplicate-therapy determination, including the claim or authorization number of the alleged duplicate

If BCBS applied this denial to SUD residential but would not apply an analogous duplicate-therapy rule to a medical or surgical inpatient admission, document the comparison explicitly — this is the foundation of a parity challenge.